| Category | Adjuvants |
| Molecular Formula | C68H132N3O19P |
| Molecular Weight | 1326.76 |
| Appearance | White Powder |
| Storage | Store at -20 °C |
4A-MPLA
4A-MPLA, the synthetic antigen-adjuvant, is employed in vaccines that bolster immune responses to infectious agents and cancers. The toll-like receptor 4 (TLR4) is vigorously activated by this powerful agonist, which, when given with other adjuvants, augments vaccine effectiveness during vaccination programs intended to combat bacterial and viral infections, including tuberculosis, influenza, and meningitis.
Structure of 2260669-09-6
Ordering Information
*For research and manufacturing use only. We do not sell to patients.
Fast-Track Access to Precise Molecular Weight Products
Professional Solutions for Molecular Research
cGMP Capacity
- cGMP-grade lipid manufacturing
- Scalable from milligrams to kilograms
- 20+ years expertise in lipid chemistry
- In-stock supply in the US and Europe
- Comprehensive QC testing with COA, MSD
- High-purity synthetic and natural lipids
- Covers phospholipids, sterols, and sphingolipids
- 100+ types of custom lipid modifications
- Specialized lipids for LNP delivery
- Functionalized and fluorescently labeled lipids
Popular Publications Citing BOC Sciences Products
- Specification
| Synonyms | Monophosphoryl Tetra-acyl Lipid A; α-D-Glucopyranose, 2-deoxy-6-O-[2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[[(3R)-3-hydroxy-1-oxotetradecyl]amino]-, 3-[(3R)-3-hydroxytetradecanoate], ammonium salt (1:1) |
| IUPACName | azanium;[(2R,3S,4R,5R,6R)-6-[[(2R,3S,4R,5R,6S)-3,6-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-4-[(3R)-3-hydroxytetradecanoyl]oxyoxan-2-yl]methoxy]-4-hydroxy-2-(hydroxymethyl)-5-[[(3R)-3-tetradecanoyloxytetradecanoyl]amino]oxan-3-yl] hydrogen phosphate |
| CanonicalSMILES | CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O)NC(=O)C[C@@H](CCCCCCCCCCC)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)O)CO)OP(=O)(O)[O-])O.[NH4+] |
| InChI | InChI=1S/C68H129N2O19P.H3N/c1-5-9-13-17-21-25-26-30-34-38-42-46-59(76)85-54(45-41-37-33-29-24-20-16-12-8-4)49-58(75)69-61-64(79)65(89-90(81,82)83)55(50-71)87-68(61)84-51-56-63(78)66(88-60(77)48-53(73)44-40-36-32-28-23-19-15-11-7-3)62(67(80)86-56)70-57(74)47-52(72)43-39-35-31-27-22-18-14-10-6-2;/h52-56,61-68,71-73,78-80H,5-51H2,1-4H3,(H,69,75)(H,70,74)(H2,81,82,83);1H3/t52-,53-,54-,55-,56-,61-,62-,63-,64-,65-,66-,67+,68-;/m1./s1 |
| InChIKey | KREAPURBNFKEHO-BNSRHSNQSA-N |
| Purity | 98% |
| Solubility | Soluble in Chloroform, Methanol, Water |
| RelatedCAS | 2260669-08-5 (free acid) |
| ShelfLife | 1 Year |
| Hygroscopic | No |
| LightSensitive | No |
Related Products
Contact our experts today for pricing and comprehensive details on our PEG offerings.
Planning to purchase or looking for custom solutions?
Get in touch with our experts today! We'll respond within 24 hours to discuss your project needs and provide a customized quote.
You May Also Be Interested In
From custom lipid synthesis to lipid nanoparticle formulation, discover complementary services tailored to your research needs.
Gain Deeper Insights
Browse related content to gain a deeper understanding of lipid synthesis and manufacturing.
PEG and PEG Derivatives
-

Nutrition, Membrane Models
-

Metabolism, Labeling
-

mRNA Delivery, Endosomal Escape
-

Cell Imaging, Tracking
-

Membrane Biology, Drug Carriers
-

Cholesterol Precursors
-

Chirality Studies, Receptor Binding
-

Bioconjugation, Imaging
-

Liposomes, Drug Delivery
-

LNP Formulation, Membrane Stability
Online Inquiry